Publications of the KKNMS
Your search in the archive “Publications of the KKNMS” returned the following results:
-
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis
Von Graetz et al, erschienen in „Mult Scler“ (Vol. 25, Nr. 5, April 2019)
-
Abundant glutamic acid decarboxylase (GAD)‐reactive B cells in gad‐antibody–associated neurological disorders
Von Thaler et al, erschienen in „Ann Neurol“ ( Vol. 85, Nr. 3, März 2019)
-
Increased cerebrospinal fluid albumin and immunoglobulin A fractions forecast cortical atrophy and longitudinal functional deterioration in relapsing-remitting multiple sclerosis
Von Kroth et al, erschienen in „Mult Scler“ (Vol. 25, Nr. 3, März 2019)
-
Blimp1 prevents methylation of Foxp3 and loss of regulatory T cell identity at sites of inflammation
Von Garg et al, erschienen in „Cell Rep“ (Vol. 26, Nr. 7, Februar 2019)
-
Optical coherence tomography angiography indicates associations of the retinal vascular network and disease activity in multiple sclerosis
Von Feucht et al, erschienen in „Mult Scler“ (Vol. 25, Nr. 2, Februar 2019)
-
Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)
Von Johnen et al, erschienen in „J Neurol“ (Vol. 266, Nr. 2, Februar 2019)
-
β-Synuclein reactive T cells induce autoimmune CNS grey matter degeneration
Von Lodygin et al, erschienen in „Nature“ (Vol.566, Februar 2019)
-
Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution
Von Masuda et al, erschienen in „Nature“ (Vol. 566, Nr. 7744, Februar 2019)
-
Calcium influx trough plasma-membrane nanopores drives axon degeneration in an animal model of multiple sclerosis
Von Witte et al, erschienen in „Neuron“ (Vol. 101, Nr. 4, Februar 2019)
-
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation
Von Pfeuffer et al, erschienen in „J Neurol“ (Vol. 266, Nr.1, Januar 2019)